| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0064 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.00058 | 1 |